Table 1.
Association of circPSD3 expression with clinicopathological characteristics in ccRCC patients.
| Characteristics | n | CircPSD3 expression | P value | |
|---|---|---|---|---|
| Low | High | |||
| Age | ||||
| <60 | 41 | 25 (60.98%) | 16 (39.03%) | 0.888 |
| ≥ 60 | 40 | 25 (62.50%) | 15 (37.50%) | |
| Gender | ||||
| Male | 50 | 29 (58.00%) | 21 (42.00%) | 0.381 |
| Female | 31 | 21 (67.74%) | 10 (32.26%) | |
| Tumor size (cm) | ||||
| ≤ 4 | 47 | 26 (55.32%) | 21 (44.68%) | 0.163 |
| > 4 | 34 | 24 (70.59%) | 10 (29.41%) | |
| Fuhrman grade | ||||
| 1 + 2 | 61 | 32 (52.46%) | 29 (47.54%) | 0.003 ∗ |
| 3 + 4 | 20 | 18 (90.00%) | 2 (10.00%) | |
| T stage | ||||
| T1-T2 | 68 | 38 (55.88%) | 30 (44.12%) | 0.030 ∗ |
| T3-T4 | 13 | 12 (92.31%) | 1 (7.69%) | |
| Metastasis | ||||
| Yes | 68 | 38 (55.88%) | 30 (44.12%) | 0.030 ∗ |
| No | 13 | 12 (92.31%) | 1 (7.69%) | |
| Total | 81 | 50 | 31 | |
∗P values are statistically significant.